Clinical trial management systems have a growing popularity. This type of software is the perfect solution for streamlining trial operations at any clinical research site. But before taking the decision of integrating such system, one should consider multiple factors that will make sure that they have chosen the perfect CTMS that is best suitable for their site’s needs....
Clinical Trial Management Systems (CTMS) are the newest and most innovative software solutions that could be integrated successfully in pharmaceutical and medical research. In fact, those organizations which have implemented such system, say that they cannot imagine how they have managed before having it. Market investigators say that in 10 years almost every trial-related company will implement a CTMS. The reason for this is attributed to the
March is Colorectal Cancer Awareness Month and Clinicubes is getting involved in putting more focus on the problem. The importance of the topic is brought about by the fact that this type of neoplasm is the second highest cause of cancer deaths in the U.S. alone. Nevertheless, it is not as widely talked about as other forms of cancer, and more than 50,000 people annually will die from the avoidable disease. The aim of the Colorectal Cancer Awareness Month is to...
The most recently conducted genetic study signalizes that the accumulation of abdominal fat is a major risk factor for development of type 2 diabetes and coronary heart disease (CHD). In particular, the research points that individuals with a...
Xarelto (rivaroxaban) is the first and only non-vitamin K antagonist oral anticoagulant. The drug is currently under assessment among high risk patients with coronary or peripheral artery disease. The major news announced by Bayer and Janssen (the developers Xarelto) is that the primary end point of the Phase III COMPASS study of the clinical trial has been met earlier. More importantly, the results are “overwhelmingly” satisfying. The medicine has shown positive safety and...
Drug approvals are the aimed goal of clinical trials so that they can positively change people’s lives and treat what have been considered incurable. Unfortunately, 2016 has been unsuccessful for newcomers since only 22 medicines have been approved by the U.S. Food and Drug Administration (FDA). The hopes of the drug-makers are focused on this year, with attention payed on which innovative formula will be a block buster and would there be any market disrupters.
US Food and Drug Administration (FDA) officially announced the approval of the first artificial pancreas for patients with type 1 diabetes. Medtronic’s MiniMed 670G hybrid closed looped system is the first device that automatically tracks the blood glucose (sugar) concentration. Based on the received data it provides the required basal insulin doses. The device is suitable for patients 14 years of age and older, diagnosed with type 1 diabetes. Aspects of...
There is one reliable way to minimize the complexity of the financial status of clinical trials and it is better management with appropriate tools. If you haven’t adopted a clinical trial management system (CTMS) yet, then you might be experiencing certain hindrances in your payment relationships. Chiefly, complicated payments in clinical trials are the result of hitherto prevailing usage of manual systems to manage payments.
Organizations, which still use spreadsheets for trial data collection, seem to increase the complexity behind the studies they conduct. Sadly, the intricacy of the advanced softwares created for data collection, makes many organizations still use spreadsheets. Nonetheless, there are various solutions emerging on the market, which can help resolve this problem. Clinical trial management systems (CTMS) are those innovative software...
CTMS, or clinical trial management system, works in favor of the optimization of clinical studies, since they grow more complex and varied. It is often that scientists and specialists involved in the process face many struggles due to the requirement to perform various tasks with less resources. What is more, it is important that the trial stays time- and
